Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Generic Gold Corp | 1WD | 21. nov 2024 | 0.03 | 0.00 |
Genertec Universal Medical Group Company Limited | 5UM | 21. nov 2024 | 0.53 | 0.00 |
Genesco Inc. | GN8 | 21. nov 2024 | 27.00 | -2.17 |
GENESIS AI CORP. | NL8 | 21. nov 2024 | 0.02 | 0.00 |
GENESIS MINERALS LTD | 3G2 | 21. nov 2024 | 1.50 | 0.00 |
Genetic Analysis | 8V8 | 21. nov 2024 | 0.03 | -19.02 |
Genetic Technologies ADR | DU80 | 21. nov 2024 | 0.69 | 0.00 |
Genetic Technologies Ltd. | DU8 | 21. nov 2024 | 0.05 | 0.00 |
GeNeuro SA | GEM | 21. nov 2024 | 0.04 | -0.93 |
Genfit | XUP | 21. nov 2024 | 4.01 | -2.91 |
GENFIT S.A. - American Depositary Shares | XUPB | 21. nov 2024 | 3.84 | -3.03 |
Genflow Biosciences Plc | WQ5 | 21. nov 2024 | 0.02 | 0.00 |
Genie Energy Ltd. Class B | 6GE | 21. nov 2024 | 14.70 | -0.68 |
GENinCode plc | 9PL | 21. nov 2024 | 0.04 | 0.00 |
Genius Metals Inc. | 0FU | 21. nov 2024 | 0.04 | 0.00 |
Genmab | GE9 | 21. nov 2024 | 193.75 | +0.83 |
Genmab A/S - American Depositary Shares | GE91 | 21. nov 2024 | 19.30 | +0.52 |
Genomma Lab Internacional SAB | GEKA | 21. nov 2024 | 1.19 | -4.03 |
Genomtec S.A. | 4VI | 21. nov 2024 | 1.52 | -0.26 |
Genor Biopharma Holdings Limited | 67N0 | 21. nov 2024 | 0.16 | +0.63 |
Genovis | 5GV | 21. nov 2024 | 2.33 | -0.43 |
Genoway | JEH | 21. nov 2024 | 3.59 | +0.28 |
Genpact Ltd | 35G | 21. nov 2024 | 43.50 | +3.52 |
Genscript Biotech Corporation | G51 | 21. nov 2024 | 1.28 | 0.00 |
GenSight Biologics S.A. | G49N | 21. nov 2024 | 0.27 | -2.34 |
Gensource Potash Corp | UGN | 21. nov 2024 | 0.04 | +7.50 |
Gentex Corporation | GTX | 21. nov 2024 | 27.80 | +1.46 |
Gentherm Inc | QA4A | 21. nov 2024 | 40.40 | +3.06 |
Gentian Diagnostics | 6FK | 21. nov 2024 | 3.48 | +2.96 |
GENTILI MOSCONI S.P.A | Z5A | 21. nov 2024 | 2.25 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.